4th Quarter - Report — HOOPER, LUNDY & BOOKMAN, P.C. for ROCHE DIAGNOSTICS CORPORATION (2023)

Firm

HOOPER, LUNDY & BOOKMAN, P.C.

Client

ROCHE DIAGNOSTICS CORPORATION

Income

$30,000

Expenses

—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to clinical diagnostic laboratory services; S. 2333 Pandemic and All-Hazards Preparedness and Response Act, issues related to public health emergency preparedness; HR 4366-Fiscal Year 2024 Minibus Appropriations relating to laboratory developed tests.

Lobbyist	Covered position, as disclosed
LISA LAYMAN	SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2333 (118th), H.R. 4366 (118th)

Medicare/Medicaid MMM

S. 1000/H.R. 2377 Saving Access to Laboratory Services (SALSA); H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023.

Lobbyist	Covered position, as disclosed
LISA LAYMAN	SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2377 (118th), S. 1000 (118th), H.R. 1691 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.